🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2010 | 56,49 | 57,45 | 56,26 | 57,41 | +1,43% | 2,11% | 716.900 |
| 25/02/2010 | 55,15 | 56,63 | 54,84 | 56,60 | +1,65% | 3,25% | 597.000 |
| 24/02/2010 | 54,86 | 55,95 | 54,62 | 55,68 | +1,37% | 2,42% | 607.000 |
| 23/02/2010 | 55,13 | 55,43 | 54,41 | 54,93 | -0,24% | 1,85% | 453.400 |
| 22/02/2010 | 54,52 | 55,52 | 54,52 | 55,06 | +0,38% | 1,83% | 700.900 |
| 19/02/2010 | 53,00 | 55,30 | 52,90 | 54,85 | -2,07% | 4,53% | 2.342.700 |
| 18/02/2010 | 57,41 | 57,93 | 55,82 | 56,01 | -3,18% | 3,68% | 1.259.100 |
| 17/02/2010 | 57,59 | 58,31 | 57,06 | 57,85 | +1,15% | 2,17% | 613.300 |
| 16/02/2010 | 59,28 | 59,30 | 55,86 | 57,19 | -4,64% | 5,80% | 1.406.600 |
| 12/02/2010 | 60,15 | 60,43 | 59,10 | 59,97 | -0,61% | 2,21% | 924.100 |
| 11/02/2010 | 59,09 | 60,48 | 58,71 | 60,34 | +1,69% | 3,00% | 549.000 |
| 10/02/2010 | 58,49 | 59,78 | 58,37 | 59,34 | +1,21% | 2,41% | 504.000 |
| 09/02/2010 | 57,49 | 59,19 | 57,49 | 58,63 | +2,34% | 2,96% | 666.800 |
| 08/02/2010 | 57,15 | 58,20 | 57,09 | 57,29 | +0,63% | 1,94% | 457.400 |
| 05/02/2010 | 56,36 | 57,17 | 55,94 | 56,93 | +0,85% | 2,18% | 598.900 |
| 04/02/2010 | 58,88 | 58,92 | 55,97 | 56,45 | -4,95% | 5,01% | 860.100 |
| 03/02/2010 | 61,50 | 61,92 | 56,91 | 59,39 | -3,37% | 8,15% | 1.080.400 |
| 02/02/2010 | 59,26 | 61,97 | 59,06 | 61,46 | +3,14% | 4,91% | 1.249.300 |
| 01/02/2010 | 59,80 | 60,00 | 59,12 | 59,59 | +0,03% | 1,47% | 425.700 |
| 29/01/2010 | 59,40 | 60,35 | 59,40 | 59,57 | +0,85% | 1,60% | 756.700 |
| 28/01/2010 | 57,86 | 59,66 | 57,60 | 59,07 | +2,62% | 3,56% | 2.809.100 |
| 27/01/2010 | 57,37 | 57,64 | 57,03 | 57,56 | -0,16% | 1,06% | 596.000 |
| 26/01/2010 | 58,24 | 58,96 | 57,05 | 57,65 | -0,95% | 3,28% | 1.461.700 |
| 25/01/2010 | 59,09 | 59,23 | 57,44 | 58,20 | -0,43% | 3,03% | 475.900 |
| 22/01/2010 | 57,86 | 59,45 | 57,86 | 58,45 | +1,23% | 2,75% | 797.100 |
| 21/01/2010 | 58,15 | 58,35 | 56,50 | 57,74 | -0,35% | 3,18% | 1.080.500 |
| 20/01/2010 | 57,96 | 58,91 | 57,48 | 57,94 | -0,60% | 2,47% | 967.200 |
| 19/01/2010 | 58,00 | 59,48 | 57,88 | 58,29 | +0,22% | 2,76% | 672.100 |
| 15/01/2010 | 59,64 | 59,72 | 57,56 | 58,16 | -2,63% | 3,62% | 1.828.800 |
| 14/01/2010 | 57,19 | 59,73 | 56,17 | 59,73 | +5,47% | 6,22% | 2.027.400 |